PGBioclin
ActivePGBioclin has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5k and a net result of €90k. Equity is shrinking by ~18.1% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. Its solvency ranks better than 15% of 522 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
54
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency28▼-72
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
2.6%
Return on assets
43.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 522 sector peers (2025).
NBB · sector comparisonPosition among 522 sector peers
Solvency
better than 15%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-03-2026, 134 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
134 d early
2024
121 d early
2023
140 d early
2022
110 d early
2021
102 d early
2020
130 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€5k▼ 96.2%
2024 · €144k
2020: €130k
2021: €186k
2022: €353k
2023: €61k
2024: €144k
2020 → 2025
Total assets
€208k▲ 16.2%
2024 · €179k
2020: €130k
2021: €187k
2022: €386k
2023: €138k
2024: €179k
2020 → 2025
Net result
€90k▼ 61.4%
2024 · €233k
2020: €125k
2021: €57k
2022: €166k
2023: €188k
2024: €233k
2020 → 2025
Working capital
€-57k
2024 · €65k
2020: €130k
2021: €186k
2022: €350k
2023: €41k
2024: €65k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€186k-€353k▲ 89.1%€61k▼ 82.7%€144k▲ 136%€5k▼ 96.2%
Operating result€72k-€219k▲ 204%€245k▲ 11.5%€299k▲ 22.1%€115k▼ 61.6%
Net result€57k-€166k▲ 193%€188k▲ 13.4%€233k▲ 23.8%€90k▼ 61.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 62% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €208k
Fixed assets
€62k▼ 21.8%
Current assets
€146k▲ 46.6%
Equity and liabilities €208k
Equity
€5k▼ 96.2%
Debt
€203k▲ 485%
The debt ratio rises from 19.3% to 97.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€132k▼
2024 · €302k
Cash flow
€107k▼
2024 · €237k
Solvency
2.6%▼
2024 · 80.7%
Current ratio
0.72▼
2024 · 2.87
Quick ratio
0.72▼
2024 · 2.87
Debt / equity
36.86▲
2024 · 0.24
ROA
43.3%▼
2024 · 130.3%
Interest coverage
1016.40▼
2024 · 3087.70
Debt
€203k▲
2024 · €35k
Debt ≤ 1 year
€203k▲
2024 · €35k
Income taxes
€25k▼
2024 · €68k
A ratio outside any meaningful range has been withheld (balance sheet total €208k, equity €5k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€179k€208k▲
Fixed assets21/28€80k€62k▼
Tangible fixed assets22/27€80k€62k▼
Plant, machinery and equipment23€6k€4k▼
Furniture and vehicles24€72k€57k▼
Other tangible fixed assets26€2k€1k▼
Current assets29/58€99k€146k▲
Amounts receivable within one year40/41€7k€27k▲
Trade receivables40€0-
Other amounts receivable41€7k€27k▲
Current investments50/53€82k€113k▲
Cash at bank and in hand54/58€8k€4k▼
Deferred charges and accrued income490/1€2k€2k▼
Equity and liabilities
Total equity and liabilities10/49€179k€208k▲
Equity10/15€144k€5k▼
Contributions10/11€5k€5k=
Profit (loss) carried forward14€139k€495▼
Amounts payable17/49€35k€203k▲
Amounts payable within one year42/48€35k€203k▲
Financial debts43-€10k
Credit institutions430/8-€10k
Trade debts44€0€45▲
Suppliers440/4-€45
Taxes, remuneration and social security45€35k€0▼
Taxes450/3€35k€0▼
Remuneration and social security454/9€0-
Other amounts payable47/48€0€193k▲
Income statement
Code20242025
Non-recurring operating income76A€14k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€17k▲
Other operating charges640/8€903€4k▲
Gross operating margin9900€303k€136k▼
Operating profit (loss)9901€299k€115k▼
Financial income75/76B€2k€610▼
Recurring financial income75€2k€610▼
Financial charges65/66B€98€130▲
Recurring financial charges65€98€130▲
Profit (loss) for the period before taxes9903€301k€115k▼
Income taxes67/77€68k€25k▼
Profit (loss) for the period9904€233k€90k▼
Profit (loss) for the period to be appropriated9905€233k€90k▼
Appropriation of the result
Profit (loss) to be appropriated9906€289k€229k▼
Profit (loss) brought forward from the previous period14P€56k€139k▲
Profit to be distributed694/7€150k€229k▲
Return on contributions (dividend)694€150k€229k▲
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
19-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
01-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2020net €233k ▲23.8%
Operating result €299k, net result €233k, both a record.
31-12
Financial
Equity above €100kEq €144k ▲136%
5 profitable years in a row build equity to €144k.
13-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
12-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €200kEq €353k ▲89.1%
3 profitable years in a row build equity to €353k.
20-04
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €57k ▼54.6%
Net result drops to €57k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 1146.98
Current ratio from 299.98 to 1146.98; short-term debt falls from €434 to €163.
31-12
Financial
Equity above €150kEq €186k ▲43.6%
2 profitable years in a row build equity to €186k.
23-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Limbourg
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Pirhettes 214834 LimbourgGround area
4,915 m²
Building footprint
197 m²
Volume, LiDAR
1,006 m³
Parcel 63029B0614/00G000, Wallonia · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63029B0614/00G000 | Wallonia | 4,915 m² | 1 · 196 m² | 9.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
875500A1LKTHKOIRAA86
Similar companies · same sector, comparable size
SEALAB
BE 0790.823.281
Etterbeek · Eq €5k
Pharma Health Consulting & Services
BE 0838.304.088
La Louvière · Eq €6k
CMAX BIOTECH CONSULTING
BE 0784.922.317
Hasselt · Eq €6k
GF. Tech
BE 0731.865.493
Awans · Eq €5k
BSOLUTIONS Technique et Innovation
BE 1008.178.705
Gembloux · Eq €6k
Of 1,177 companies in sector 72109 we hold annual accounts for 715. 131 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-05-2020
Fiscal year end31-12
Activities, NACEBEL
72109Other research and development on natural sciences
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.